There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

Hers is a relatively new telehealth platform that offers prescription medications and customized support for weight loss. The ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

It comes as the weight loss company had been struggling under $1.6billion (£1.2billion) of debt after losing business to ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

RiskHedge helps investors profit from disruption by providing research on the latest breakthrough technologies and the stocks ...